Re-induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2

Elizabeth A. Raetz, Mitchell S. Cairo, Michael J. Borowitz, Xiaomin Lu, Meenakshi Devidas, Joel M Reid, David M. Goldenberg, William A. Wegener, Hui Zeng, James A. Whitlock, Peter C. Adamson, Stephen P. Hunger, William L. Carroll

Research output: Contribution to journalArticle

47 Scopus citations

Fingerprint Dive into the research topics of 'Re-induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2'. Together they form a unique fingerprint.

Medicine & Life Sciences